Bedside to bench translation
DRUG DISCOVERY SERVICES
Our close interactions with the hospital highly contributed to the development of appropriate translational rodent models that mirror human diseases. Because same aberrant oscillatory patterns are found both in human patients and in our models, outcomes smoothly translate. Our translational EEG biomarkers approach therefore makes SynapCell’s approach highly predictive.
TRANSLATIONAL models OF BRAIN DISEASES
Models proposed in our portfolio express translational EEG biomarkers that are identical to the ones found in human.
Such step forward is the result of years of R&D and intense validation steps, using the back translation power of EEG to predict a drug in-human efficacy at the preclinical step.
We can EEG phenotype your own model of interest and discover together a novel EEG biomarker that could turn out to be a game changer for you. For us, an efficient model is stable, can be used to monitor quantifiable parameters and is translational.
Any brain structure is at reach for our skilled lab techs, from surface (cortex) to deep areas (Striatum, hippocampus) in a minimally-invasive way.
Our project kick-off meeting with you will enable to select the most appropriate design, paradigm and protocol to identify EEG signatures of the disease or pharmacological pathway you are working on.
Our EEG platform (Cue®) offers EEG, qEEG, ERP, ASSR phenotyping and much more!